openPR Logo
Press release

Polymerase Chain Reaction (PCR) Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth

08-08-2025 04:58 PM CET | Health & Medicine

Press release from: The Business Research Company

Polymerase Chain Reaction (PCR)

Polymerase Chain Reaction (PCR)

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Polymerase Chain Reaction (PCR) Market Size By 2025?
The scale of the Polymerase Chain Reaction (PCR) market has experienced significant expansion in the recent past. The market, valued at $11.42 billion in 2024, is projected to escalate to $12.67 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 11.0%. Factors contributing to this growth during the historic period include a surge in the number of research facilities, a rise in the prevalence of chronic and infectious diseases, an increased incidence of genetic and chronic disorders, population growth, and an aging population.

How Big Is the Polymerase Chain Reaction (PCR) Market Size Expected to Grow by 2029?
The market size of the polymerase chain reaction (PCR) is projected to undergo considerable expansion in the forthcoming years, with projections indicating a growth to $18.97 billion in 2029, at a compound annual growth rate (CAGR) of 10.6%. This forecasted growth in the PCR market can be ascribed to mounting concerns about food safety, greater demand for safe and high-quality food commodities, escalating demand for molecular diagnostics, and personalized medicine needs, along with a focus on digital polymerase chain reaction (dPCR). Significant trends forecasted for this period encompass real-time polymerase chain reaction, the advancements in DNA sequencing technologies and diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the development of superior molecular diagnostic solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report

Which Key Market Drivers Powering Polymerase Chain Reaction (PCR) Market Expansion and Growth?
The growth of the polymerase chain reaction (PCR) market is anticipated to be driven by the burgeoning requirement for personalized medicine. Personalized, or precision, medicine means a healthcare approach that individualizes health decisions, proceedings, strategies, and treatments based on each patient's unique attributes. The drive for personalized medicine is escalating due to advancements in data analytics, patient-specific treatment responses, and the ability to customize therapies according to individual genetic blueprints. Personalized medicine is enabled by PCR, which allows for the amplification and examination of particular genetic sequences, letting medical practitioners modify treatment strategies as per individual genetic outlines. For example, as reported by the US-based professional membership organization, the Personalized Medicine Coalition, in 2022, the approval of 12 new personalized medicines constituting around 34% of all freshly approved therapies, signifying a considerable rise from preceding years. Thus, the escalating need for personalized medicine is fueling the expansion of the polymerase chain reaction market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Polymerase Chain Reaction (PCR) Market?
Key players in the polymerase chain reaction market are creating real-time polymerase chain reaction testing kits to enhance precision, productivity, and user-friendliness in genetic analysis. The real-time polymerase chain reaction (RT-PCR), a lab-produced test kit, is used to magnify and measure specific DNA sequences in real-time. For example, Cepheid, a molecular diagnostics firm based in the US, introduced the Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This is an FDA-approved multiplex PCR test capable of identifying DNA from organisms linked with three separate vaginal infections - bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis from a single vaginal swab sample. By offering real-time tracking, quantification, and elevated sensitivity and specificity, it enhances the traditional polymerase chain reaction techniques, making it an essential asset in molecular biology and clinical diagnostics.

What Are the Emerging Segments in the Polymerase Chain Reaction (PCR) Market?
The polymerase chain reaction (PCR) market covered in this report is segmented -

1) By Type: Conventional Polymerase Chain Reaction, Other Types
2) By Indication: Infectious Diseases, Oncology, Genetic Disorders, Other Indications
3) By Application: Medical, Non-Medical
4) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industries, Diagnostic Centers, Academic And Research Organization

Subsegments:
1) By Conventional Polymerase Chain Reaction: Endpoint Pcr, Gel Electrophoresis-Based Pcr, Reverse Transcription Pcr (Rt-Pcr), Quantitative Pcr (Qpcr) For Gene Expression, Nested Pcr
2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr), Digital Pcr (Dpcr), Multiplex Pcr, Reverse Transcription-Quantitative Pcr (Rt-Qpcr), Isothermal Amplification (Lamp), Next-Generation Pcr (Ngs-Based Pcr Techniques), High-Throughput Pcr

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15638&type=smp

Who Are the Global Leaders in the Polymerase Chain Reaction (PCR) Market?
Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

Which are the Top Profitable Regional Markets for the Polymerase Chain Reaction (PCR) Industry?
North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15638

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polymerase Chain Reaction (PCR) Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth here

News-ID: 4138845 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for PCR

Emerging Trends to Reshape the Global Real-Time PCR, Digital PCR And End-Point P …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Real-Time PCR, Digital PCR And End-Point PCR Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market encompassing real-time PCR, digital PCR, and end-point PCR has experienced robust expansion over the past few years, projecting a rise from $38.37 billion in 2024 to $41.55 billion
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
The PCR And Realtime PCR Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current PCR And Realtime PCR Testing Market Size and Its Estimated Growth Rate? The PCR and real-time PCR testing market has grown strongly, rising from $10.55 billion in 2024
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size? There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size? There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is
Q-PCR and D-PCR Devices Market: Revolutionizing Molecular Diagnostics
The Q-PCR and D-PCR devices market has experienced significant growth in recent years, driven by advancements in molecular biology and the increasing demand for accurate and sensitive diagnostic tools. These technologies have revolutionized the field of molecular diagnostics, enabling researchers and clinicians to detect and quantify specific DNA or RNA sequences with high precision. Market Size and Growth The global Q-PCR and D-PCR devices market is estimated to be worth billions of
Real-Time PCR, Digital PCR And End-Point PCR Global Market Analysis, Trends, Gro …
The new report published by The Business Research Company, titled "Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the real-time pcr, digital pcr and end-point pcr market size has grown strongly